2007
DOI: 10.1080/02841850701280775
|View full text |Cite
|
Sign up to set email alerts
|

Gadolinium contrast agent is of limited value for magnetic resonance imaging assessment of synovial hypertrophy in hemophiliacs

Abstract: The optimal time interval for volume assessment of synovial hypertrophy after injection of gadolinium contrast agent is dose dependent. Hemophiliacs without recent bleeds have minor to abundant synovial hypertrophy in joints with pronounced radiographic changes. Dynamic MRI is not useful for evaluating hemophilic arthropathy, and gadolinium contrast agent is not routinely indicated for MRI scoring of joints in hemophiliacs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
17
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(19 citation statements)
references
References 35 publications
2
17
0
Order By: Relevance
“…In keeping with these observations, Pettersson radiographic scores which indicate advanced bony changes correlated significantly with synovial thickness on both imaging studies in adults but not in children which has also been reported by Lundin et al. on MRI [20]. Nuss et al.…”
Section: Discussionsupporting
confidence: 77%
See 1 more Smart Citation
“…In keeping with these observations, Pettersson radiographic scores which indicate advanced bony changes correlated significantly with synovial thickness on both imaging studies in adults but not in children which has also been reported by Lundin et al. on MRI [20]. Nuss et al.…”
Section: Discussionsupporting
confidence: 77%
“…MRI studies were acquired with a 3.0T GE (General electric, Milwaukee, WI, USA) scanner using a single‐channel linear extremity coil. Gadopentetate dimeglumine (Gd‐DTPA) (Magnevist ® ; Berelx Laboratories, Wayne, NJ, USA) was used as a paramagnetic contrast agent at a concentration of 0.1 m m kg −1 as previously described [20]. Dynamic contrast enhanced (DCE) perfusion studies were acquired using a 3D FAME (Fast Acquisition with Multiphase Enhanced) gradient echo sequence as previously described [21].…”
Section: Methodsmentioning
confidence: 99%
“…Consequently, the sensitivity and positive predictive value of POC‐US in the evaluation of synovial hypertrophy may have been overestimated in our study. However, this is unlikely as synovial hypertrophy according to the IPSG MRI score is evaluated using robust surface measurements in a single MRI slice only . Therefore, MRI with contrast is not expected to change the classification of synovial hypertrophy according to the haemophilia specific MRI score.…”
Section: Discussionmentioning
confidence: 99%
“…However, Lundin et al. [14] showed that routine enhanced MR imaging did not improve the evaluation of synovial hypertrophy. The need for improved quantitative assessment methods should be taken into account when developing new imaging techniques and software.…”
Section: Discussionmentioning
confidence: 99%
“…This is qualitative not quantitative evaluation, but it is still very helpful for monitoring synovial changes during treatment. We did not evaluate quantitatively the hypertrophied synovium changes even on the enhanced MR imaging, although other authors have evaluated the synovial changes [10,14], with a semiquantitative assessment. However, Lundin et al [14] showed that routine enhanced MR imaging did not improve the evaluation of synovial hypertrophy.…”
Section: Discussionmentioning
confidence: 99%